
Glumight M 2mg/500mg Tablet ER
Marketer
Werke Healthcare
Salt Composition
Glimepiride (2mg) + Metformin (500mg)
Overview Glumight M 2mg/500mg Tablet ER
Diabelite Duo 2mg/500mg Extended-Release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabelite Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial, even with well-controlled blood sugar, as discontinuation without medical supervision can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, it's a component of a comprehensive diabetes management plan incorporating a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize its symptoms – sweating, dizziness, headache, trembling – and how to manage them. Consistent meal timing and carrying a fast-acting glucose source (e.g., sugary snacks, juice) are preventative measures. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Disclose any history of heart disease to your physician prior to commencing treatment. Pregnant or lactating women should seek medical counsel before use. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended.
Uses of Glumight M 2mg/500mg Tablet ER
Managing Type 2 diabetes
Major Benefits of Glumight M 2mg/500mg Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the Glumight M 2mg/500mg Extended-Release tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.
Common Side effects of Glumight M 2mg/500mg Tablet ER:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Glumight M 2mg/500mg Tablet ER:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Glumight M 2mg/500mg Extended-Release tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.
How Glumight M 2mg/500mg Tablet ER works:
Glumight M 2mg/500mg Extended-Release tablets combine glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glumight M 2mg/500mg Extended-Release tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The extended-release Glumight M 2mg/500mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Extended-release Glumight M tablets (2mg/500mg) are contraindicated for breastfeeding mothers due to potential infant toxicity.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Glumight M 2mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glumight M 2mg/500mg Extended-Release tablets. Physician consultation is essential. Regular monitoring of kidney function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glumight M 2mg/500mg Extended-Release Tablets cautiously. Dosage modification may be necessary. Consult your physician. For those with mild to moderate liver disease, initiation should be at a low dose; it's contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Glumight M 2mg/500mg Tablet ER :
Should you forget to take your Glumight M 2mg/500mg Extended-Release tablet, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glumight M 2mg/500mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
